Polar Capital Holdings Plc Has $1.79 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Polar Capital Holdings Plc cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 96.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,970 shares of the company's stock after selling 159,309 shares during the period. Polar Capital Holdings Plc's holdings in HCA Healthcare were worth $1,792,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $36,000. Activest Wealth Management grew its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the period. Finally, Legacy Investment Solutions LLC boosted its position in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded down $0.94 during trading on Tuesday, hitting $385.95. 1,361,442 shares of the stock were exchanged, compared to its average volume of 1,435,007. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market capitalization of $92.85 billion, a price-to-earnings ratio of 17.57, a price-to-earnings-growth ratio of 1.10 and a beta of 1.46. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company's fifty day simple moving average is $342.18 and its 200-day simple moving average is $328.51.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the company earned $5.36 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.75%. HCA Healthcare's payout ratio is 12.81%.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

HCA has been the subject of a number of recent analyst reports. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Royal Bank of Canada cut their price target on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.